ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 229 filers reported holding ARENA PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 2.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $17,865,000 | +16.4% | 300,000 | +33.3% | 5.14% | +21.6% |
| Q2 2021 | $15,345,000 | +5.3% | 225,000 | +7.1% | 4.22% | +1.4% |
| Q1 2021 | $14,572,000 | -5.2% | 210,000 | +5.0% | 4.16% | -8.9% |
| Q4 2020 | $15,366,000 | +37.0% | 200,000 | +33.3% | 4.57% | +33.2% |
| Q3 2020 | $11,219,000 | +1.8% | 150,000 | -14.3% | 3.43% | +4.0% |
| Q2 2020 | $11,016,000 | +138.4% | 175,000 | +59.1% | 3.30% | +62.1% |
| Q1 2020 | $4,620,000 | +45.3% | 110,000 | +57.1% | 2.04% | +64.4% |
| Q4 2019 | $3,179,000 | – | 70,000 | – | 1.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 164,300 | $9,633,000 | 4.86% |
| Atika Capital Management LLC | 230,000 | $13,485,000 | 2.65% |
| DAFNA Capital Management LLC | 93,942 | $5,508,000 | 2.07% |
| PFM Health Sciences, LP | 1,828,378 | $107,198,000 | 2.04% |
| Perceptive Advisors | 1,380,171 | $80,919,000 | 1.86% |
| Eversept Partners, LP | 73,501 | $4,309,364 | 1.21% |
| Partner Investment Management, L.P. | 18,159 | $1,065,000 | 1.13% |
| Rhenman & Partners Asset Management AB | 170,000 | $9,967,000 | 1.10% |
| EMERALD ADVISERS, LLC | 425,510 | $24,948,000 | 1.00% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 388,418 | $22,773,000 | 0.90% |